Guerbet SA (EPA: GBT)

France flag France · Delayed Price · Currency is EUR
27.15
+0.45 (1.69%)
Jan 20, 2025, 5:35 PM CET
44.72%
Market Cap 342.33M
Revenue (ttm) 840.79M
Net Income (ttm) 32.76M
Shares Out 12.61M
EPS (ttm) 2.60
PE Ratio 10.45
Forward PE 9.64
Dividend 0.50 (1.87%)
Ex-Dividend Date Jul 1, 2024
Volume 7,718
Average Volume 11,566
Open 26.70
Previous Close 26.70
Day's Range 26.50 - 27.30
52-Week Range 18.26 - 40.25
Beta 0.80
RSI 51.29
Earnings Date Mar 25, 2025

About Guerbet

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1926
Employees 2,920
Stock Exchange Euronext Paris
Ticker Symbol GBT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.